Patent expiry and biosimilars: difference between revisions
Diff·revision 5 → 6·05:32, 26 Jan 2025
Difference between revision 5 and revision 6 of Patent expiry and biosimilars. This revision changed no lines of source — the edit was a null or whitespace change.
| Revision 5 — 15:35, 14 Jan 2025 TrialsTabitha (talk) add the citation for the regulatory action 2,578 bytes +736 | Revision 6 — 05:32, 26 Jan 2025 ShortageShona (talk) add the patent-expiry statement, attributed and dated 2,578 bytes ±0 | ||
|---|---|---|---|
| — | No change to the page source. | — |